skip to primary navigationskip to content
 

Taking parked therapies into overdrive

last modified Apr 28, 2014 04:09 PM
Healx3 is aiming to breathe new life into parked therapeutics and dormant IP in the biopharmaceutical industry.

 

The start-up, based at ideaSpace West, hopes to take the medical technology parked by biopharmaceutical companies and turn it into new drugs and therapies. Healx3 is currently in talks with biopharma companies on potential partnerships.

In an interview with Business Weekly, CEO Tim Guilliams, who holds a PhD in molecular neuroscience from the University of Cambridge, says: “Around 90 per cent of drug development projects never make it to market – leaving a vast amount of parked bio-assets on company benches.

“Some of these assets still have therapeutic potential, but do not cure patients or generate revenue. Healx3 is specialising in the upcycle and out-licensing of parked therapeutics and dormant IP in the biopharmaceutical industry.

“By enabling companies to generate new revenue streams and promote collaborative innovation within the industry, our activities will help deliver the next generation of therapeutics to patients in need.”

Healx3 is currently self-funded but aims to seek angel support once it has created strategic partnerships, launching a pilot with around 10 assets and pushing for seed capital around September.

To read the full article visit here

For more on Healx3 see http://www.healx3.com/

RSS Feed Latest news

Greg Law: Building a Successful Tech Business

Sep 26, 2018

Greg Law is the co-founder and CTO of Undo; a diagnostic software tool which helps companies respond quickly to software failures and improve software quality. From building the business on a part time basis from Greg's garden shed, to growing to a team of 40 and raising over $20M in investment, Undo have firmly established themselves on the tech industry map. We caught up with Greg to find out more about his experiences leading a successful business.

Steve Marsh: 6 Ways to Grow Your Business

Aug 07, 2018

We met with Steve Marsh, Founder and CEO of GeoSpock; originally a student from Manchester who arrived in Cambridge to study his PhD, before developing his business idea into a flourishing reality

The Secrets to Simprints' Success

Jun 27, 2018

We met up with Simprints co-founder and CTO Tristram Norman to ask his advice on growing a business from 'a year of Sundays' project to a team of 25.

Mixcloud raises $11.5m from WndrCo

Apr 17, 2018

Audio streaming platform raises first ever funding round

FreeAgent Acquired by RBS in £53m Deal

Mar 28, 2018

Accounting software specialist FreeAgent has been bought by a subsidiary of Royal Bank of Scotland for £53 million.

View all news